Sarepta Therapeutics Inc. (SRPT)

122.78
2.64 2.10
NASDAQ : Health Technology
Prev Close 125.42
Open 125.38
Day Low/High 122.22 / 126.41
52 Wk Low/High 72.05 / 158.80
Volume 543.96K
Avg Volume 1.14M
Exchange NASDAQ
Shares Outstanding 74.54M
Market Cap 9.35B
EPS -5.50
Div & Yield N.A. (N.A)
Not Dead Yet

Not Dead Yet

Two names down in the dumps but showing a little life.

Searching for Clarity

Searching for Clarity

This market is messy and uneven.

Sarepta downgraded at Piper

Caveat Emptor

Sarepta Therapeutics is the disaster du jour. The disaster du jour, a stock often mentioned in our comments section (Jack's favorite equity) and on message boards, is Sarepta Therapeutics (SRPT).

Heed the Warning Signs

Heed the Warning Signs

Not to be overly negative, but increased awareness can't hurt.

Market Still Sees a Deal

Market Still Sees a Deal

Are we setting up for some sort of sell-the-news reaction?

A Market at the Mercy of Politicians

A Market at the Mercy of Politicians

If a deal doesn't actually happen tonight, Friday's opening will be brutal.

Markets Dance to the Headlines

Markets Dance to the Headlines

While money rotates into conservative and defensive names.

The Market Caved

The Market Caved

But how long will it last?

A Healthy Pullback

A Healthy Pullback

The market had gotten a bit frothy and needed to reset.

Momentum Chasers Save the Day

Momentum Chasers Save the Day

They have little fear that a bounce could fail.

Dr. Stockstalker

Dr. Stockstalker

How I Learned to Stop Worrying and Love Market Correction.

Cracks Appear

Cracks Appear

The bears have been waiting for it -- now it's here.

Talk, Talk, Talk

Talk, Talk, Talk

Until there's a change in price action, that's all the bears can do.

A Paucity of Perky Picks

A Paucity of Perky Picks

Pockets of momentum are drying up and upside movement is narrowing.

Morning Call, July 24

Morning Call, July 24

Brittany Umar and Scott Redler, chief strategic officer at T3Live.com, reveal how to trade stocks ahead of earnings season: retail, banks, tech.

Logical Arguments Don't Matter

Logical Arguments Don't Matter

Momentum doesn't need justification.

Individuals Stand Strong

Individuals Stand Strong

We are seeing some hot pockets of momentum.

Bulls Have a Tough Slog Ahead

Bulls Have a Tough Slog Ahead

Overcoming these poor charts won't be easy.

A Market With No Memory

It can turn so quickly and totally forget poor action.

Bobbing for Biotech

Bobbing for Biotech

Let's look at four possibilities.

Take Your Cues From the Market

Take Your Cues From the Market

Trying to outthink it just doesn't pay.

Requiem for the Bears

Requiem for the Bears

If there are any bears left, I hope they aren't trying to short during this bull rampage.

Still Plenty of Buying Interest

Still Plenty of Buying Interest

Action in individual stocks was impressive despite the struggling indices.

Sarepta downgraded at Leerink

Walking the High-Wire

Walking the High-Wire

Hope you aren't afraid of heights.

Stuck in a Middle Zone

Stuck in a Middle Zone

Where it's easy to make impatient trades that don't do much.

Brace for a New High

Brace for a New High

End-of-month window-dressing could be the catalyst.

Building a Foundation

Building a Foundation

We remain in an uptrend and have not breached any key technical levels.

The Slow, Steady Climb Continues

The Slow, Steady Climb Continues

Being anticipatory or overly reactive is a good way to find yourself out of position.